Adcendo vs Alchemab Therapeutics
Adcendo vs Alchemab Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adcendo is on 60/100 and Alchemab Therapeutics on 42/100.
Where each one leads
Adcendo
- our overall score: 60/100 against 42/100
- funding raised: $272M against $31.5M
Alchemab Therapeutics
- domain rating: 33/100 against 28/100
At a glance
| Measure | Adcendo | Alchemab Therapeutics |
|---|---|---|
| What it is | Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need. | Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals. |
| Category | Biotechnology, Pharmaceuticals, Oncology, Drug Discovery | Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2017 | 2019 |
| Headquarters | Copenhagen, Denmark | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Adcendo | Alchemab Therapeutics |
|---|---|---|
| Employees | 60 | Not published |
| Total funding | $272M | $31.5M |
| Latest round | Series C | Series A |
| LinkedIn followers | 9,847 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adcendo | Alchemab Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 42/100 |
| Traction | 58/100 | 37/100 |
| Team | 70/100 | Not published |
| Search visibility | 34/100 | 8/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adcendo | Alchemab Therapeutics |
|---|---|---|
| Hosting | Self Managed | Google Cloud |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Adcendo vs Alchemab Therapeutics: common questions
Which is better, Adcendo or Alchemab Therapeutics?
On our 0-100 score Adcendo rates higher (60/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Adcendo and Alchemab Therapeutics compare on the numbers?
Adcendo leads on our overall score (60/100 against 42/100), funding raised ($272M against $31.5M). Alchemab Therapeutics leads on domain rating (33/100 against 28/100).
Read the full Adcendo review and pricing or the Alchemab Therapeutics review and pricing. You can also browse other Adcendo alternatives we track.